Jacqueline Allan

Dr. Jacqueline Allan has been engaged in the development of science, technology and innovation policy advice at national and international levels for over fifteen years. Within the S&T Policy Division at the OECD (Organisation for Economic Co-operation and Development, Paris), she leads the Secretariat for the OECD Working Parties on Biotechnology and Nanotechnology, working globally with governments on policy for synthetic biology; biomedical innovation; and industrial biotechnology; and on policy issues of responsible development, skills, education, public engagement and commercialisation of nanotechnology and other enabling technologies.

A physicist by training, Dr Allan is the author of numerous analytical and advisory reports on science, technology, industry and education policy; and on evaluations of international and national programmes for the OECD, Forfás (the Irish national agency for science, technology and industry policy) and the EC. She has been a delegate to both OECD and EU policy advisory bodies including ERAC and ESFRI.

Imre Berger
Topic: Folding and secretion of recombinant proteins

Imre Berger was trained as a biochemist at Leibniz University and Medical School (MHH) in Hannover (Germany), MIT (Cambridge, USA), and ETH Zurich (Switzerland). He researches multiprotein complexes in human health and disease, and develops enabling technologies for this purpose..
Dr. Berger is Group Leader at EMBL Grenoble with a joint appointment in the EMBL Genome Biology Program, Heidelberg. He is member of the International Unit of Virus Host-Cell Interactions (UVHCI) and directs the eukaryotic expression facility (EEF) at the EMBL.
Dr. Berger has developed the award-winning MultiBac system for multiprotein expression. Funded by the European Commission, he has installed EMBL’s MultiBac platform for protein complex production. Dr. Berger holds international patents for expression technologies, and received numerous distinctions, including the Swiss Technology Award and the W.A. DeVigier Foundation Award for his innovative research. He will present recent developments and successful applications of his technologies in academic and industrial R&D.

Elizaveta Bonch-Osmolovskaya
Topic: Exploitation of metagenomics for environmental and biocatalytic applications

Elizaveta Bonch-Osmolovskaya is a Deputy Director of Winogradsky Institute of Microbiology, Russian Academy of Sciences, and the Head of the Laboratory of hyperthermophilic microbial communities in the same Institute. Since many years she is studying diversity, ecology and metabolism of thermophilic prokaryotes. She participates in many national and international research programs, including FP7 Project Hotzyme: Microbial diversity and metagenomic mining for
biotechnological innovation. Elizaveta participated in many expeditions in the regions of hydrothermal c activity all over the world; she is the author of 145 experimental and review articles and of 8 book chapters. In 2012 she received Winogradsky Award of the Russian Academy of Sciences and became a foreign member of the American Academy of Microbiology.

Tim Bugg
Topic: Bioprocessing

Tim Bugg is Professor of Biological Chemistry at the University of Warwick. His academic career started at the University of Southampton in 1991, where his group studied enzymes involved in the bacterial degradation of aromatic compounds and enzymes involved in bacterial peptidoglycan assembly. Since moving to Warwick in 1999, his group has more recently studied enzymes involved in bacterial degradation of lignin, and the application of biocatalysis to convert lignin into renewable aromatic chemicals. He is the author of the undergraduate textbook “Introduction to Enzyme and Coenzye Chemistry”.


Bernd Bukau
Topic: Stress responses in microbial bioprocessing

Bernd Bukau studied biology at the Universities of Besançon and Konstanz and received his PhD in bacterial genetics at the University of Konstanz. After a postdoc at the Massachusetts Institute of Technology (USA), he built up a research group at the Center for Molecular Biology of the University of Heidelberg (ZMBH). In 1997 he took over the chair in biochemistry at the Medical Faculty of the University of Freiburg. Since 2002 he is professor for molecular biology at the ZMBH in Heidelberg and is Director of this Center since 2004. Since 2012 he is also the head of a bridging unit at the German Cancer Research Center (DKFZ) and since 2008 he is Co-Director of the Alliance between the ZMBH and the German Cancer Research Center (DKFZ). B. Bukau has received several research awards including the Gottfried Wilhelm Leibniz-Price of the German Science Foundation and is member of EMBO. His research focus are the regulation of protein homeostasis and the mechanisms of molecular chaperones in protein folding and repair.

Roberto De Philippis
Topic: Assimilation of CO2, CO and CH4 into biobased products

Roberto De Philippis is professor of Microbial Biotechnology at the University of Florence, Italy, Department of Agrifood Production and Environmental Sciences, and Associate Researcher at the Institute of Chemistry of Organometallic Compounds, Italian National Research Council, Florence. His research activity is mainly concerned with the physiology and the possible biotechnological exploitation of phototrophic microorganisms. He is President elect of the International Society for Applied Phycology and Assistant Editor of the Journal of Applied Phycology. He is Italian Delegate in the International Energy Agency- Hydrogen Implementing Agreement (IEA-HIA) New Annex 21 “Bio-inspired and Biological Hydrogen” and member of the Experts group of the Section on Environmental Biotechnology of the European Federation of Biotechnology.

Satyahari Dey

Professor Satyahari Dey has been in the Faculty of Biotechnology in the Indian Institute of Technology Kharagpur (IIT Kharagpur) since 1988, has served as the Head of the Department of Biotechnology for 3 years (2003-06) and is currently as the Professor (since 2003).
Professor Dey’s major area of R&D is bioprospecting the bioactive healthcare molecules from plants and microbes. One major aspect of thrust is developing new prebiotic carbohydrate molecules as the substrates for human gut microbiome.
Professor Dey nurtures keen interest in bio-entrepreneurship and bio-innovation, and has been associated with the science & technology entrepreneurship park (STEP) as well as the technology incubation and entrepreneurship training society (TIETS) of IIT Kharagpur (for promoting start ups by graduating students).

Fabio Fava
Topic: Biowaste biorefinery for a more sustainable bioeconomy

Fabio Fava (1963), with a Laurea degree in “Chemistry and Pharmaceutical Technologies” (University of Bologna, Italy) and a Ph.D. in “Applied Microbiology” (ICT, University of Prague, Czech Republic), is Full Professor of “Industrial & Environmental Biotechnology” at the University of Bologna (Italy). He has about 120 papers on medium/high IF peer-review international journals of industrial and environmental biotechnology where he is working in the frame of the FP7 EU projects NAMASTE and BIOCLEAN (as coordinator), ECOBIOCAP, BIOCHEM, MINOTAURUS, ULIXES, ROUTES, WATER4CROPS and KILL SPILL. He is the Deputy Chair of the “Environmental Biotechnology” section of EFB and member of the “Task Force on Industrial Biotechnology” of OECD. Further, he is joining the "High Level Group on Key Enabling Technologies" and the "Expert Group on biobased products" of the DG-ENTR, as well as the "Expert Group on eco-industries" of the DG-JRC (European Commission). Finally, he is the Italian Representative in the Horizon2020 Programming Committee “European Bioeconomy Challenges: Food Security, Sustainable Agriculture and Forestry, Marine, Maritime and inland water research" at the European Commission.
Wolf-Dieter Fessner

Wolf-Dieter Fessner is Full Professor of Organic Chemistry at the Technische Universitaet Darmstadt since 1998. He studied Chemistry and Medicine and obtained his PhD from the University of Freiburg (1986), following which he carried out postdoctoral research at Harvard University with George M. Whitesides and at the University of Southern California with George A. Olah. After completing his Habilitation on the development of novel biocatalysts for carboligation (1992), he assumed a position as Associate Professor at the RWTH Aachen.

His primary research interest is focused on the development of practical methods for asymmetric organic synthesis at the interface between chemical and biological catalysis. A distinctive element in his research is the assembly and development of one-pot, multi-enzymatic reaction cascades for stereoselective carbon-carbon bond formation and efficient oligosaccharide synthesis. This includes the design of suitable assay technology for the discovery of novel biocatalytic activities as well as the characterization and engineering of novel enzyme catalysts for a broader spectrum of substrate specificity.

Sabine Flitsch
Topic: Glycobiotechnology

Sabine Flitsch graduated with a Diplom in Chemistry from the University of Münster (Germany) and obtained her DPhil in 1985 from the University of Oxford. She spent three years at the Massachusetts Institute of Technology, USA as a Research Fellow (with H. G. Khorana) before returning to the UK to hold academic positions at the Universities of Exeter, Oxford, Edinburgh and Manchester. She is currently Professor of Biological Chemistry at the University of Manchester with her research group housed at the Manchester Institute of Biotechnology (MIB).

Her research interests are on the interface of chemistry and biology with focus on applications in Biotechnology. Her focus is on glycobiotechnology, using biocatalysis for the synthesis of complex carbohydrates and glycoconjugates such as glycolipids, glycoproteins, polysaccharides, glycomaterials and glycoarrays. These glycoarrays are used to discover new carbohydrate-protein interactions using mass spectrometry as a label-free analytical tool.

Martin Fussenegger

Martin Fussenegger is Professor of Biotechnology and Bioengineering at the Department of Biosystems Science and Engineering (D-BSSE) of ETH Zurich in Basel as well as at the University of Basel. He graduated with Werner Arber at the Biocenter of the University of Basel (1992), obtained his Ph.D. in Medical Microbiology (1994) at the Max Planck Institute of Biology (Tübingen) and continued his postdoctoral studies on host-pathogen interactions at the Max Planck Institute of Infection Biology (Berlin, 1995). Subsequently, he joined the ETH Institute of Biotechnology (1996), where he received his habilitation in 2000, and became Swiss National Science Foundation Professor of Molecular Biotechnology in 2002, prior to being awarded a Chair in Biotechnology and Bioengineering at the ETH Institute for Chemical and Bioengineering in 2004. On a presidential mission, he moved to Basel in 2008 to build up the D-BSSE of the ETH Zurich. Martin Fussenegger is a fellow of the American Institute for Medical and Biological Engineering (AIMBE) and a member of the Swiss Academy of Engineering Sciences.

Paul Gatenholm
Topic: New biomedical materials

Dr. Gatenholm is currently professor of Biopolymer Technology at Chalmers University of Technology, Director of Biosynthetic Blood Vessels Laboratory, Coordinator of EAREG program and Director of Graduate School at Wallenberg Wood Science Center, WWSC. He is also Adjunct Professor at Joint School of Biomedical Engineering and Sciences at Virginia Tech and Wake Forest University and Adjunct Professor of Biomaterials at Wake Forest Institute for Regenerative Medicine in Winston-Salem, North Carolina, USA. He has been professor of Bioprocessing and Biomaterials at the Virginia Tech, Department of Materials Science and Engineering between August 2007 and April 2009. Dr. Gatenholm is a material scientist with interest in the biomimetic design of materials. His research includes biological fabrication through the use of enzymes, cells, and the coordination of biological systems. Dr. Gatenholm is particularly interested in designing and preparing new biomaterials which can replace or regenerate tissue and organs. He has published more than 200 peer review papers and edited several books. He is elected member of Royal Academy of Engineering Sciences.

Anne Glover

Professor Anne Glover joined the European Commission as Chief Scientific Adviser to the President in January 2012, and is the first person to hold this position.
In this role she advises the President on any aspect of science and technology, liaises with other science advisory bodies of the Commission, the Member States and beyond, coordinates science and technology foresight, and promotes the European culture of science to a wide audience, conveying the excitement and relevance of science to non-scientists. She also chairs the recently established Science & Technology Advisory Council of the President.
Prior to her current appointment she was Chief Scientific Adviser for Scotland from 2006-2011. Professor Glover currently holds a Personal Chair of Molecular and Cell Biology at the University of Aberdeen. Most of her academic career has been spent at the University of Aberdeen where she has a research group pursuing a variety of areas from microbial diversity to the development and application of whole cell biosensors (biological sensors) for environmental monitoring and investigating how organisms respond to stress at a cellular level.
Professor Glover holds several honorary doctoral degrees and is an elected Fellow of the Royal Society of Edinburgh, the Society of Biology, the Royal Society of Arts and the American Academy of Microbiology. Professor Glover was recognised in March 2008 as a Woman of Outstanding Achievement in the UK and was awarded a CBE for services to Environmental Science in the Queen’s New Years Honours list 2009.
Harald Gröger

Harald Gröger studied Chemistry at the Universities of Erlangen-Nürnberg and Oldenburg and received his diploma degree in Chemistry from the University of Oldenburg in 1994. He carried out his doctoral thesis at the University of Oldenburg under the supervision of Prof. Dr. Martens. After receiving his doctoral degree in 1997, he stayed as a postdoctoral fellow at the University of Tokyo in the group of Prof. Dr. Shibasaki from 1997 to 1998. In 1998 he joined the research department Chemische Forschung of SKW Trostberg AG. After the merger with Degussa-Hüls AG to Degussa AG in 2001, he became Project Manager in the Project House Biotechnology of Degussa AG. From 2004 to 2006 he worked as a Senior Project Manager at the research unit Service Center Biocatalysis of Degussa AG. From 2006 to 2011 he was W2-Professor (Associate Professor) of Organic Chemistry at the University of Erlangen-Nürnberg and since April 2011 he is W3-Professor (Full Professor) of Organic Chemistry at Bielefeld University. Harald Gröger and his teams were awarded the Degussa InnovationAward 2003 (category: new products) and the Degussa Innovation Award 2005 (category: new or improved processes). In addition, he was awarded the Carl-Duisberg-Memorial-Prize 2008 of the German Chemical Society (GDCh) and very recently the Otto Roelen Medal 2014 of the DECHEMA and the German Catalysis Society (GeCatS). His main research areas center on the use of bio- and chemocatalysts in organic synthesis and the development of sustainable and industrially feasible production technologies.
Georg M. Gübitz

Georg M. Gübitz, Austrian Biotechnologist, grad. 1993 and Ph.D. 1996 Graz Univ. Technology. He has spent one year in Central America investigating upgrading of byproducts from oil seed plant processing. As a Erwin-Schroedinger Fellow, he developed enzyme based strategies for lignocellulose processing at Univ. British Columbia, Canada from 1996 – 98. That work demonstrated the potential of enzymes to replace toxic chemicals and to lower energy consumption in polymer processing thereby reducing the negative environmental impact. Back at TU-Graz and later as a full professor at Univ. of Natural Resources and Life Sciences, Vienna and head of the Institute of Environmental Biotechnology he created a large network in enzyme based polymer processing. He participated in 26 European projects and coordinated 11 out of which. His achievements in the development of environmentally friendly processes resulted in various awards, 12 patents and more than 250 peer reviewed publications.
Jay Keasling

Jay Keasling received his B.S. in Chemistry and Biology from the University of Nebraska in 1986; his Ph. D. in Chemical Engineering from the University of Michigan in 1991; and did post-doctoral work in Biochemistry at Stanford University from 1991-1992. Keasling joined the Department of Chemical Engineering at the University of California, Berkeley as an assistant professor in 1992, where he is currently the Hubbard Howe Distinguished Professor of Biochemical Engineering. Keasling is also a professor in the Department of Bioengineering at Berkeley, a Sr. Faculty Scientist and Associate Laboratory Director of the Lawrence Berkeley National Laboratory and Chief Executive Officer of the Joint BioEnergy Institute. Dr. Keasling’s research focuses on engineering microorganisms for environmentally friendly synthesis of small molecules or degradation of environmental contaminants. Keasling’s laboratory has engineered bacteria and yeast to produce polymers, a precursor to the anti-malarial drug artemisinin, and advanced biofuels and soil microorganisms to accumulate uranium and to degrade nerve agents.

Oscar Kuipers
Topic: Synthetic biology replacements for antibiotics

Oscar Kuipers obtained a Masters degree in Molecular Biology at the University of Utrecht in 1986 and got his PhD in Utrecht in Biochemistry in 1990. He started postdoctoral research at NIZO food research and was appointed group leader in 1997. He was appointed full professor of Molecular Genetics of Prokaryotes at the University of Groningen in 1999.
His group employs physiological, genetic, biochemical and functional-genomics aspects of Gram-positive bacteria (Bacillus subtilis, Bacillus cereus, Lactococcus lactis, Streptococcus pneumoniae) in particular on the elucidation and visualization of complex gene regulatory networks. His main current research interests are in engineering posttranslationally modified antimicrobial peptides, developing novel antibiotics by synthetic biology approaches, studying the molecular biology of sporulation and competence development in Bacilli, studying the origin of phenotypic heterogeneity in isogenic cultures, experimental cellular evolution, and in several biotechnological applications. Various national and international collaborations exist, in particular within the scope of EU and ESF programs. His group participates in the Top Institute Food and Nutrition, as well as in the Kluyver Center for Genomics of Industrial Fermentation. Oscar Kuipers has been involved in over 300 publications in international journals, as well as in 16 patent applications. He has been chairman of the Dutch Biotechnology Association, and is Board member of the Royal Dutch Society of Microbiology. In 2011 he was awarded the STW Simon Stevin Meester award (500,000 euro for breakthrough biotechnology research) and was also appointed member of the Royal Dutch Academy of Arts and Sciences.
Eveline Lecoq

Eveline Lecoq is working in the Unit "Bio-based Products and Processes" of the Directorate General Research & Innovation of the European Commission. She has been significantly involved for the Commission in the development of the European Bioeconomy Strategy presented in February 2012 as well as in the establishment of a new Public Private Partnership on Bio-based Industries that was adopted in May 2014. Ms Lecoq has a background in life sciences, science communication and applied environmental economics. Before joining the Commission, she worked for European and international companies for several years, in particular in regulatory affairs for the biotechnology industry.

Gary Loake
Topic: Plants for production of high value chemicals

Gary Loake is Professor of Genetics and Genomics at the University of Edinburgh, where he is leader of Edinburgh Industrial Biotechnology, a cross institution theme. Together with Unhwa, Gary was the first to describe the isolation, characterisation and culture, on an industrial scale, of plant stem cells, which can be utilised as production platforms for key pharmaceuticals. He is a member of the Scientific Advisory Board for Unhwa and also sits on the boards of the Caribbean Research and Development Institute and the UK High Value Chemicals from Plants Network. Gary is a Governing Board member of the recently established Scottish Industrial Biotechnology Innovation Centre (IBioIC). He is also President elect of the International Plant Reactive Oxygen and Nitrogen Species Group, an Honorary Professor at the Institute of Genetics and Developmental Biology, Chinese Academy of Sciences and an Honorary Fellow of the James Hutton Research Institute. He has also been a member of numerous grant boards and institution advisory groups.

Matthias Lutolf
Topic: Stem cell applications and Gene thereapies: where are we?

Professor Matthias Lutolf directs the Laboratory of Stem Cell Bioengineering at the Institute of Bioengineering (IBI), EFPL. He was trained as a Materials Engineer at ETH Zurich where he also carried out his Ph.D. studies on the development of a novel class of biomaterials for tissue engineering (awarded with ETH medal in 2004). Lutolf carried out postdoctoral studies at the Baxter Laboratory in Stem Cell Biology at Stanford University on microenvironmental (‘niche’) regulation of somatic stem cells (2005-2007). He started up his independent research group at EPFL with a European Young Investigator (EURYI) award. By interfacing advanced biomaterials engineering, microtechnology and stem cell biology, a major goal in his lab is to uncover mechanisms of stem cell fate regulation; knowledge that will contribute to better ways to grow stem cells in culture and use them for various applications.
Paula Marques Alves

Paula Marques Alves is the CEO of IBET (2012-…) and coordinates the Animal Cell Technology Unit of IBET/ITQB-New University of Lisbon (2007-…). She is invited Associate Professor at the FCT-New Univ Lisbon (2011-…). She did her PhD in Biochemical Engineering in 2001 at ITQB.
Since 1995, Paula Alves has focused her research on understanding cell metabolism to improve the efficiency of bioprocesses and at developing new tools and technologies for pre-clinical research. Through her career she has been using Animal Cell Technology for R&D in particular for: (i) production of complex biopharmaceuticals such as viral vectors, vaccines and recombinant proteins, (ii) development of 3D culture systems for toxicity testing - using primary cultures and stem cells - and for expansion and differentiation of stem cells in bioreactors for cell therapy applications and (iii) application of systems biology approaches to organize the complexity of the processes involved in the research described in (i) and (ii).
CV Highlights: 158 published papers, 12 book chapters, supervised 14 PhD students and 12 post-docs. Participation in 9 EU FP6 and FP7 projects (WP leader in 6), 11 research projects with international Pharma and Biotec Companies and several projects funded by FCT (Portugal).
In addition, Paula M Alves is currently Vice-President of the ESACT-European Society for Animal Cell Technology and member of the Horizon 2020 Advisory Group for Societal Challenge 1 - Health, Demographic Change and Wellbeing. She serves numerous scientific committees in international conferences and is reviewer for several international committees (BSRC/BRIC‐UK, NSF‐USA, Welcome Trust/India, ANR-France, ETMR‐Scotland, A‐Star, EU‐FP7).

Pierre Monsan
Topic: Robust biocatalysts for the production of novel bio-based products

Pierre Monsan (65) is Professor Emeritus at the National Institute for Applied Sciences of the University of Toulouse, and Professor at Mines ParisTech (Department of Biotechnology). He is Head of the Executive Board and Founder of the pre-industrial demonstrator “Toulouse White Biotechnology (TWB)”.

He has been active for 44 years in the field of enzyme catalysis (enzyme production, purification, immobilization and application, screening, structural characterization and molecular design). He authored more than 220 scientific publications, 2 books and 62 patents. His H-factor is 35.
He was involved in the founding of several start-up companies: BioEurope (1984), BioTrade (1996), Genibio (1998) and in the move of LibraGen from Lyon to Toulouse (2004).

He is a founding member of the French Academy of Technology, Deputy-chairman of the French Federation of Biotechnology, member of the Executive Board of the European Federation of Biotechnology and French representative at the Board of the International Carbohydrate Organization.

John Pickett
Topic: Plant genetic engineering

Professor John A. Pickett is originally an organic chemist (BSc 1967, PhD 1971, DSc 1993), recognised for services to Biological Chemistry, CBE, 2004 and worldwide e.g. Wolf Prize in Agriculture, 2008, for investigations into a group of volatile natural products, semiochemicals, that affect the behaviour and development of animals and other organisms and particularly their interactions with plants. Recent successes include laboratory and field research into GM based release of the aphid alarm pheromone and a practical programme for controlling stem borer pests and striga weeds in collaboration with Professor Zeyaur Khan’s group, ICIPE, Africa. He headed the Department of Biological Chemistry at Rothamsted Research from 1984-2010 and now holds the first Michael Elliott Distinguished Research Fellowship.

Jack Pronk
Topic: Evolutionary strategies for cell factory development

Jack Pronk (1963) holds an MSc (Plant Molecular Biology) from Leiden University and a PhD (Microbiology) from the Delft University of Technology. In 1991, he joined the Delft Industrial Microbiology group as assistant professor and in 1999 became full professor. Jack was co-founder and, from 2002-2013, director of the Kluyver Centre for Genomics of Industrial Fermentation, a national Centre of Excellence. Jack’s fascination for the physiology of industrial micro-organisms – with Saccharomyces yeasts as important model organisms - is inspired by their industrial application. Improvement of microbial performance by metabolic engineering and laboratory evolution is another key topic in his research. Jack is (co)author of over 200 scientific publications and (co)inventor on 20 patent applications. His love for teaching is reflected by his active involvement in the Delft-Leiden BSc/MSc ‘Life Science and Technology’ curricula and in the annual Advanced Course on Microbial Physiology and Fermentation Technology taught @Delft.

Erik Reimhult
Topic: Nanotechnology: new biological applications

Prof. Erik Reimhult is since 2010 head of the Institute for Biologically inspired materials at the University of Natural Resources and Life Sciences Vienna. He got his PhD in Physics and Engineering Physics in 2004 from Chalmers University of Technology. Reimhult has worked as postdoctoral researcher at the Institute of Materials Research and Engineering Singapore and as senior scientist at the Department of Materials at the ETH Zurich on biointerfaces, biosensing, nanofabrication, polymer surface modifications, supramolecular assembly, and multi-functional nanoparticles. In 2012 Reimhult was awarded an ERC Starting Grant Award for research on nanoparticle-membrane interactions and elected member of the Austrian Academy of Sciences Junge Kurie. His current research focus is the development of new synthetic approaches to biomimetic particles such as core-shell nanoparticles, colloidal strings and externally controlled vesicles, as well as development of new colloidal and surface sensitive methods to investigate their structure-function relationships.
   Andreas Schmid

Molly Stevens
Topic: Biomarkers and diagnostic tools

Molly Stevens is currently Professor of Biomedical Materials and Regenerative Medicine and the Research Director for Biomedical Material Sciences in the Institute of Biomedical Engineering at Imperial College. She joined Imperial in 2004 after a Postdoctoral training at the Massachusetts Institute of Technology (MIT). Prior to this she graduated from Bath University with a First Class Honours degree in Pharmaceutical Sciences and was then awarded a PhD from the Laboratory of Biophysics and Surface Analysis at the University of Nottingham (2000). She has been recognised by numerous awards including the 2012 EU40 Award for top materials scientist in Europe and Technology Review’s TR100, a compilation of the top young innovators worldwide, who are transforming technology - and the world with their work. Her group is focussed on both high quality fundamental science and translation for human health in the regenerative medicine and biosensing fields.

Christoph Wittmann
Topic: Applications of metabolic modelling

Christoph Wittmann, born 1967, is Professor and Managing Director of the Institute of Systems Biotechnology at the Saarland University in Saarbrücken, Germany. Prior to his current position, he received his PhD in biotechnology at the German Research Institute for Biotechnology (GBF) in Braunschweig, was Postdoc at the University of Helsinki, research group leader at the Biochemical Engineering Institute at Saarland University, Professor for Biotechnology at Münster University and Professor for Biochemical Engineering at the Braunschweig University of Technology as well as Co-director of the Braunschweig Integrated Centre for Systems Biology and the Centre for Pharmaceutical Engineering. He has published 140 journal papers and 10 book contributions. He holds 15 patents and patent applications. He has received the PhD award of the German Research Institute of Biotechnology and the Young Scientist Award of the European Federation of Biotechnology. His research interests comprise systems and synthetic biology and biotechnology, fluxomics and metabolomics, in-silico pathway modelling, systems metabolic engineering and industrial biotechnology with a focus on white biotechnology. He currently runs national and international projects on sustainable bio-production of chemicals, materials and high-value therapeutics, using e.g. E. coli, C. glutamicum, B. subtilis, E. coli and P. putida. Novel research interests focus on medical systems biology and towards better understanding of pathogenic bacteria (P. aeruginosa, E. coli, Y. pseudotuberculosis, M. tuberculosis).

Sang Yup Lee

Sang Yup Lee received B.S. in Chem. E. from Seoul National University, and Ph.D. in Chem. E. from Northwestern University. Currently, he is Distinguished Professor, Dean of KAIST Institutes, and Director of Center for Systems and Synthetic Biotechnology, BioProcess Engineering Research Center, and Bioinformatics Research Center at KAIST. He has published more than 450 journal papers, and 550 patents. He received many awards, including the National Order of Merit, Citation Classic Award, Elmer Gaden Award, Merck Metabolic Engineering Award, ACS Marvin Johnson Award, SIMB Charles Thom Award, and Amgen Biochemical Engineering Award. He is currently Fellow of AAAS, TWAS, AIChE, American Academy of Microbiology, Society for Industrial Microbiology and Biotechnology, American Institute of Medical and Biological Engineering, Korean Academy of Science and Technology, and National Academy of Engineering of Korea, and Foreign Associate of National Academy of Engineering USA. He is Editor-in-Chief of Biotechnology Journal and editor of many journals.